Nanjing Hicin Pharmaceutical Co., Ltd.

SZSE:300584.SZ

26.36 (CNY) • At close November 27, 2023
Bedrijfsnaam Nanjing Hicin Pharmaceutical Co., Ltd.
Symbool 300584.SZ
Munteenheid CNY
Prijs 24.7
Beurswaarde 2,964,000,000
Dividendpercentage 0%
52-weken bereik 20.3 - 41
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Yuping Cao
Website https://www.hicin.cn

An error occurred while fetching data.

Over Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (CNY)

Cijfers zijn in miljoenen (CNY)